2017 Weekly Broadcast Archive

 

12/26/2017  Weekly Broadcast: RTOG 0926; RTOG 1306; RTOG 1112; GOG-0229O; GOG-0274/RTOG 1174
12/20/2017   Study Closure - RTOG 1306
12/20/2017 NRG-HN004 Training Session and Webinar
12/19/2017 NRG Oncology Winter Holiday Hours 
12/18/2017  RTOG 0926 Closure Notice 
12/18/2017 Weekly Broadcast: NRG-HN004; NRG-GI004
12/15/2017 NRG-HN004 Training Session at NRG Meeting
12/12/2017  NRG-HN004 Protocol Activation 
12/11/2017 Weekly Broadcast: NRG-CC001, RTOG 0924, NSABP B-55/BIG 6-13
12/5/2017  Study Closure Announcement - RTOG 1306
12/4/2017 Weekly Broadcast: NRG-HN001; GI003; GI004; GU002; GY009; RTOG 0924
11/28/2017 NRG Oncology at SABCS 2017
11/27/2017  Weekly Broadcast: GOG-0281; NRG-BR003 
11/20/2017 Weekly Broadcast: GOG-0274/RTOG 1174; NRG-GY004; NRG-GY005
11/17/2017  NRG-GU005 Protocol Activation
11/13/2017  Weekly Broadcast: NSABP B-55/BIG 6-13; NRG-GY004; NRG-GY005  
11/7/2017 NRG-GI004 Protocol Activation
11/6/2017 Weekly Broadcast: NRG-CC001; NRG-HN001; NRG-GY004; NRG-GY005; RTOG 1008
11/2/2017 NRG Oncology Semiannual Meeting Registration is Now Open
11/2/2017 NRG-GY004 Closure - Myriad Testing Update
10/30/2017 Weekly Broadcast: NRG-GY004; NRG-CC004; NRG-GY005
10/26/2017 NRG-GY004 will close on Nov. 10, 2017
10/23/2017  Weekly Broadcast: NRG-HN001; NSABP B-55/BIG 6-13; NRG-BR003; GOG-0184 
10/20/2017 Medical Oncology Committee Updated Call for Applications
10/18/2017 Publications Update: Predatory publishers
10/18/2017 NRG-GY004 Anticipated Closure Info
10/17/2017 Olaparib Action Letter/Protocol Amendments for NRG-GY004, NRG-GY005, and NSABP B-55
10/17/2017  PROTOCOL NRG-HN001: Temporary Closure and Protocol Error Affecting Patient Safety
10/16/2017 Weekly Broadcast: NRG-CC003; NRG-GY009; NRG-BN001; NRG-BR002; NRG-BR005; NRG-GI002; RTOG 1008
10/11/2017  PROTOCOL NRG-CC003: Temporarily Closed to Accrual 
10/9/2017  NRG-HN003 reopened to accrual at Schedule Level 3 
10/9/2017 Weekly Broadcast: NRG-GY007
10/4/2017 NRG Oncology/GOG-0240 Published in The Lancet
10/2/2017  Weekly Broadcast: AGCT1531, NRG-BN001, NSABP B-55/BIG 6-13, NRG-GY004 
9/28/2017  Save the Date! - Semiannual Meeting
9/25/2017 Weekly Broadcast: NRG-CC001, NRG-CC003, NRG-BN005
9/20/2017 RFP from Elderly Working Group
9/18/2017 Weekly Broadcast: NRG-HN001
9/14/2017 GYN Commiittee Application
9/12/2017 Mannel Appointed as an NRG Oncology Group Chairman
9/12/2017 NRG Oncology Newsletter Vol. 4 2017
9/11/2017  Weekly Broadcast: RTOG 0839, NRG-GY004, NRG-GY005  
9/7/2017 Shipments to Houston Update
9/5/2017 Weekly Broadcast: NSABP-B-BB/BIG 6-13; NRG-GI002
9/1/2017 NRG-GY006: Reactivation
8/31/2017  Biospecimen Collection Update – NRG-RTOG 0920, NRG-BN001 and NRG-BR002 
8/29/2017  NRG Oncology Hurricane Harvey Update (Additional Information) 
8/29/2017  NRG Oncology Hurricane Harvey Update 
8/28/2017 NRG-GY003: Closure
8/28/2017  Weekly Broadcast: NRG-GY003, NRG-BR002, NSABP B-55/BIG 6-13, NRG-GY004 
8/25/2017 NRG-GY011: Activation
8/24/2017 NRG-GY003: Tentative Closure Date
8/23/2017 NRG-GY003: Patient Consent Suspension
8/21/2017 Weekly Broadcast: NRG-BR001, NRG-GY009
8/17/2017 NRG-BR001: Mediastinal/Cervical Lymph Node closure
8/14/2017  Weekly Broadcast: GOG-9902, RTOG 0834/EORTC 26053_22054/NCIC CTG CEC.1, NRG-CC004, RTOG 0534
8/9/2017  Erlotinib and Crizotinib Action Letters/Protocol Amendment for RTOG 1306 
8/7/2017 Weekly Broadcast: NRG-BN003, BN005, GI003, GU003, GY008, HN001; RTOG 0631
8/3/2017 DTRT subcommittee now accepting membership applications
8/2/2017  PROTOCOL RTOG 0631 – CLOSURE 
8/2/2017  NRG-BN005 Protocol Activation
7/31/2017 Weekly Broadcast: NRG-GI002, NRG-GY003, NRG-GY004, NRG-GY005, NRG-GY009; NSABP B-55; RTOG 1119
7/28/2017  NRG-GU003 Protocol Activation  
7/26/2017  PRESS RELEASE: NRG-RTOG 0436 in JAMA Oncology 
7/24/2017 Weekly Broadcast: GOG-0207, NRG-BN001, RTOG 1008
7/17/2017  Weekly Broadcast: RTOG 0534, GOG-0286B, NRG-GI002, NRG-GY004, NRG-GY005  
7/12/2017  NRG-BN003 Protocol Kick-Off/Information Session 
7/11/2017  Ixazomib and Pevonedistat Project Team Member Application 
7/11/2017  NRG Oncology Newsletter Vol. 3 2017 
7/10/2017 Weekly Broadcast: NRG-HN001, NSABP B-55, NRG-GY009
7/3/2017  Weekly Broadcast: RTOG 0825, NRG-GY006, NRG-HN003, NRG-BN003, NRG-BR002, NRG-GY003, NRG-GY004 
6/30/2017  NRG Oncology Protocol RTOG 0825 - STUDY TERMINATION
6/29/2017 NRG-GY009: ACTION LETTER and Amendment 1
6/26/2017 Weekly Broadcast: NRG-BR005, GOG-0281, NRG-BN003, NRG-BR001, NRG-BR002, NRG-CC004, NRG-GI002
6/22/2017 NRG-BR005 Re-activation
6/22/2017  NRG-GI003 Protocol Activation
6/20/2017 Webinar for NRG-RTOG 0848 will be held this Friday (6/23)
6/19/2017  Weekly Broadcast: NRG-GI001, NRG-BN003, NSABP B-47
6/16/2017 NRG-GY005 temporary closure
6/15/2017  REGISTER TODAY - NRG-RTOG 0848 Webinar 
6/14/2017  NRG-BN003 Protocol Activation
6/12/2017 Weekly Broadcast: NRG-BN001, GY005; NSABP B-55/BIG 6-13
6/9/2017  Save the Date for NRG-RTOG 0848 Webinar 
6/8/2017 NRG Oncology Newsletter Vol 2, 2017
6/5/2017  Protocol NRG-HN003 - Study Memorandum to Accompany CTEP-Distributed Action Letter for MK-3475 (pembrolizumab, NSC 776864)
6/5/2017 Weekly Broadcast: GOG-0213, NSABP B-51/RTOG 1304
6/2/2017  NRG-HN003 Temporarily Closed to Accrual 
6/1/2017 GOG 0274/RTOG 1174 Closure to accrual
5/31/2017  NRG-CC004 Protocol Activation 
5/30/2017 Weekly Broadcast: NRG-BN001, GI002, GY004, GY005, GY006; GOG-0274; AGCT1531; ASCO
5/23/2017  Protocol NRG-BR001-Central Lung site conditionally reopened 
5/22/2017  Weekly Broadcast:  NRG-GY003, NRG-GI001, NSABP B-55/BIG 6-13
5/18/2017  GOG-0274/RTOG 1174 OUTBACK: Closure to screening& consent on June 1, 2017
5/16/2017 NRG-GY009 only open to Safety-Lead in Participants
5/15/2017  Weekly Broadcast: NRG-GY006, GOG-0278, NRG-CC001, NRG-CC003, NRG-HN003
5/12/2017 NRG-GY009 Activation
5/11/2017  Robert L. Comis, MD, Group Co-Chair, ECOG-ACRIN Cancer Research Group 
5/8/2017 NRG-BR005 Temporary Accrual Suspension
5/8/2017 Weekly Broadcast: GOG-0281, NRG-BR002, NRG-CC001, NRG-CC003, GOG-0279
5/1/2017 Weekly Broadcast: NRG-GY008, NRG-CC001, NRG-CC003, NRG-BR002, NSABP B-55/BIG 6-13, NSABP B-51/RTOG 1304
4/25/2017
NSABP B-55 Amendment and Suspension
4/24/2017
Weekly Broadcast: NRG-BN001, NRG-GY004, NRG-GY005, NSABP B-51/RTOG 1304, NRG-GI001, GOG-0274/RTOG 1174
4/20/2017 PSC Accepting Applications for Working Groups
4/19/2017  REMINDER: Soliciting Applications for NCORP CCDR 
4/19/2017  REMINDER: Soliciting Applications for NCORP CPC 
4/19/2017 CTN/CRA Subcommittee Vacancies
4/19/2017  NRG-HN003 Amended and Reopened to Accrual
4/17/2017 Weekly Broadcast: NRG-BR005, NRG-CC001, NRG-CC003, NSABP B-51/RTOG 1304, NRG-GI001
4/13/2017 NRG-BR005 Protocol Activation
4/10/2017  Weekly Broadcast:  GOG-0076HH, GOG-0186I, GOG-0130F, GOG-0231D, GOG-0240, GOG-0248, GOG-9927; NSABP B-39/RTOG 0413, NRG-GI001, NRG-GY008; RTOG 0825, NSABP B-55/BIG 6-13, NRG-GI002, NRG-GY004, NRG-GY005, NRG-GY008
4/7/2017  NRG-LU002 Protocol Activation 
4/3/2017 Weekly Broadcast: RTOG 0929; NRG-CC001; NRG-CC003; NSABP B-55/BIG 6-13; NRG-BR003
3/29/2017  Protocol NRG-HN003 - Temporarily closed to Accrual 
3/27/2017  Weekly Broadcast: NRG-GI002; NRG-GU002  
3/20/2017 Weekly Broadcast: GOG-0283, 0265; NSABP B-51; NRG-BR001, GY007
3/17/2017  PROTOCOL NRG-BR001 – Abdominal/Pelvic site conditionally reopened 
3/16/2017  Clarification regarding NRG NCORP Cancer Care Delivery Research (CCDR) Request for Applications 
3/14/2017  Soliciting Applications for NCORP CCDR
3/14/2017  Soliciting Applications for NCORP CPC 
3/14/2017  CB-839 Project Team Member Application 
3/13/2017 Weekly Broadcast: RTOG 1106; NRG-BR003, GU002
3/6/2017 RTOG 1106 - Closure Notice
3/6/2017 Weekly Broadcast: GOG-9929, 0225; NRG-GY001, GY004, GY005, GY008, BR003, GU002; NSABP B-53, B-55 
3/1/2017 Action Letter: NRG-GY001
2/27/2017 Weekly Broadcast: RTOG 0517; NRG-BR003 GU002; GY004: GY005; NSABP B-55; 
2/20/2017  Weekly Broadcast: NRG-GU002; GOG-0286B; NRG-GY008; NRG-CC001; NRG-CC003
2/13/2017  Weekly Broadcast: NRG-GY002; NRG-GY003; NRG-GI002; NRG-HN001; 
2/7/2017  Protocol NRG-HN002 - Closure 
2/6/2017 Weekly Broadcast: NRG-HN002; GOG-0265; RTOG 1112
2/3/2017 Action Letters: NRG-GY002, GY003; GOG-9929
2/3/2017  PROTOCOL NRG-HN002 – CLOSURE NOTICE 
2/2/2017  PRESS RELEASE: NRG-RTOG 9601 in NEJM and Highlighted on nytimes.com 
2/1/2017  NRG-GU001 - Study Closure and Termination, Effective Immediately  
1/30/2017  Weekly Broadcast: RTOG 0825; NRG-GI002, GY007, GY008
1/26/2017  PRESS RELEASE: NRG-RTOG 0525 in JAMA Oncology 
1/23/2017  Weekly Broadcast: NSABP B-55/BIG 6-13, NRG-GI002, NRG-GY008, GOG-0274/RTOG 1174
1/20/2017  Reminder! NSABP B-55/BIG 6-13 Enrollment Notice 
1/18/2017  Protocol NRG-HN002, Nearing Accrual Target 
1/16/2017 Weekly Broadcast: GOG-0281; NRG-GY004, GY005, GY006; RTOG 1119; NSABP B-55
1/9/2017 Weekly Broadcast: NRG-GY007; GY008
1/6/2017 NRG Oncology Newsletter Vol. 1 2017
1/3/2017 Weekly Broadcast: NRG-GU002, RTOG 0912, RTOG 0938, NRG-CC003, RTOG 0924, RTOG 0920, NRG-HN001, NRG-HN002, RTOG 1106, NSABP B-51/RTOG 1304

Stay current with science. Sign up for our newsletter.

Support NRG Oncology.
Help Our Cause.

We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More

Donate Today

NRG Oncology Foundation, Inc, is a nonprofit, tax-exempt foundation. Donations to NRG Oncology help us conduct this important mission, and are tax-deductible to the extent permitted by law.